+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Oncology Compendium

  • Book

  • March 2025
  • Elsevier Science and Technology
  • ID: 5978199

Medical Oncology Compendium discusses several important topics in oncology with the help of leading experts worldwide who incorporate not only knowledge on recent developments in the field, but contextualize them within diverse socioeconomic environments to guarantee the applicability of the content in challenging scenarios. The book comprehensively discusses topics such as surgery, radiology, carcinogenesis, screening, assessment tools, evidence-based medicine, and precision oncology as applicable to different cancer types as non-small and small cell lung cancer, mesothelioma, breast cancer, gastric-rectal cancer, female specific cancers, prostate, skin and bone sarcomas.

In addition, it discusses options to minimize oncology pain and palliative care. It is a valuable resource for oncologists, clinicians, researchers, healthcare workers and members of biomedical field who needs to understand more about diagnosis, treatment options and support for cancer patients.

Table of Contents

1. Principles of medical oncology
2. Principles of surgeon oncology
3. Principles of radiation oncology
4. Molecular mechanisms of carcinogenesis
5. Cancer Screening and diagnosis
6. Pharmacological basis of the Anti-cancer Drugs
7. Principles of pharmaco-economy and decision making in oncology
8. Health Technologies Assessment Tools in oncology
9. Biostatistics in oncology (evidence-based medicine)
10. Radiological response assessment methods in oncology
11. The role of interventional radiology in oncology
12. Innovation Technologies & Precision Oncology
13. Small Cell Lung cancer
14. Mesothelioma
15. Thymus
16. Breast Cancer Screening
17. Breast Diagnosis Techniques
18. Early Breast Cancer
19. Metastatic Breast Cancer
20. Oesophageal
21. Gastric
22. Colon
23. Rectal
24. Anal Canal Cancer
25. Small intestine
26. Hepatocellular Carcinoma
27. Pancreatic Cancer
28. Ovarian
29. Cervical
30. Vagina
31. Gestacional trophoblastic disease
32. Prostate Cancer
33. Renal Cell Carcinoma
34. Urothelial Cancer
35. Germ-Cell Tumors
36. Squamous Head and neck
37. Thyroid cancer
38. Parotid Gland Tumors
39. Non-melanoma skin cancer
40. Melanoma skin cancer
41. Soft Tissue Sarcomas
42. Bone Sarcomas
42. GIST
44. NET
45. Primary brain tumor
46. Hodgkin Lymphoma
47. Non-Hodgkin Lymphoma
48. Multiple Myeloma
49. Acute Lymphoblastic Leukemia
50. Acute Myelogenous Leukemia
51. Chronic Myeloid Leukemia
52. Crhonic Lymphocitic Leukemia
53. Myelodisplastic Syndrome
54. Anti-cancer drugs Imuno-related adverses events
55. Metabolic disturbance/paraneoplasic syndromes
56. Spinal medular compression
57. Superior vena cava syndrome
58. Febrile neutropenia
59. Chemotherapy-Induced Nausea and Vomiting
60. Asthenia
61. Oncological pain
62. Bone Metastases
63. Brain metastasis
64. Palliative care

Authors

Ramon Andrade B de Mello Professor of Medical Oncology, Escola Paulista de Medicina, Federal University of Sao Paulo, S�o Paulo, Brazil. Prof. Ramon Andrade Bezerra de Mello is a board-certified medical oncologist in Portugal, UK, and Brazil. He has over 19 years of clinical and academic experience in Europe where he worked full time in well reputed cancer institutions, such as Portuguese Institute of Oncology of Porto, University of Porto, Portugal, and Edinburgh Cancer Center, UK. Since, Prof. Mello delivered his tasks as a humanized and high-level doctor dedicated to providing the best care for his patients alongside the vanguard of oncology research, as well as teaching medical students and training juniors doctors. Currently, he is the Head of the Discipline of Medical Oncology at the Translational Medicine Post-Graduation Program and Head of the Lung & Skin Medical Oncology Clinic at Paulista School of Medicine, UNIFESP. In addition, he is Director of the Precision Oncology and Health Economics Research Group with more than 20 national/international members in a core structure with the Post-Graduation Program of Medicine, Nine of July University, in collaboration with UNIFESP and Faculty of Medicine & Biomedical Sciences, University of Algarve, Portugal, where he is still invited Professor of Oncology.